国际医学：2025年第三季度公司管理费用率10.99%

Core Insights - The company is enhancing operational efficiency while optimizing the quality of medical services through clinical pathway management, reducing drug consumption ratio, and optimizing cost structure [1] Financial Performance - As of Q3 2025, the company's management expense ratio is 10.99%, a year-on-year decrease of 0.54 percentage points and a quarter-on-quarter decrease of 2.13 percentage points [1] - The financial expense ratio stands at 3.43%, with a year-on-year decrease of 0.07 percentage points and a quarter-on-quarter decrease of 0.25 percentage points, indicating initial success in cost control [1]